홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Methanol → 4-[[N-(2-amino-4,5-difluorobenzoyl)glycyl]aminomethyl]-1-(benzo[c]furazan-5-yl)piperidine

HRID 279336
인쇄

반응식

HRID 279336 반응식
C(OC([NH:8][C:9]1[CH:28]=[C:27]([F:29])[C:26]([F:30])=[CH:25][C:10]=1[C:11]([NH:13][CH2:14][C:15]([NH:17][CH2:18][CH:19]1[CH2:24][CH2:23][NH:22][CH2:21][CH2:20]1)=[O:16])=[O:12])=O)(C)(C)C.BrC[C:33]1[CH:41]=[CH:40][C:36]2=[N:37][O:38][N:39]=[C:35]2[CH:34]=1.C1CCNCC1.CO>C(Cl)(Cl)Cl.C(#N)C>[NH2:8][C:9]1[CH:28]=[C:27]([F:29])[C:26]([F:30])=[CH:25][C:10]=1[C:11]([NH:13][CH2:14][C:15]([NH:17][CH2:18][CH:19]1[CH2:20][CH2:21][N:22]([C:33]2[CH:41]=[CH:40][C:36]3=[N:37][O:38][N:39]=[C:35]3[CH:34]=2)[CH2:23][CH2:24]1)=[O:16])=[O:12]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 887MethanolHCID 8082PiperidineHCID 27355875-(Bromomethyl)-2,1,3-benzoxadiazoleHCID 184262024-[[N-(2-(tert-butoxycarbonylamino)-4,5-difluorobenzoyl)glycyl]aminomethyl]piperidine

생성물 1

HCID 184262184-[[N-(2-amino-4,5-difluorobenzoyl)glycyl]aminomethyl]-1-(benzo[c]furazan-5-yl)piperidine

시약·촉매·용매 2

HCID 6212
Chloroform
용매
HCID 6342Acetonitrile용매

반응 조건

온도
50 °C

실험 절차

A mixture of 4-[{N-(2-(tert-butoxycarbonylamino)-4, 5-difluorobenzoyl)glycyl}aminomethyl]piperidine (0.050 mmol), 5-(bromomethyl)benzo[c]furazan (0.75 mmol), (piperidinomethyl)polystyrene (2.6-2.8 mmol/g, 60 mg, 0.15 mmol), methanol (0.2 mL), acetonitrile (1.0 mL), and chloroform (0.50 mL) was stirred at 50° C. overnight. The mixture was cooled to room temperature, loaded onto Varian™ SCX column, and washed with CH3OH (5 mL×2). Product was eluted off using 2 N NH3 in CH3OH (5 mL) and concentrated. To the resulting material were added chloroform (1.5 mL) and phenyl isocyanate (0.075 mL) and the solution was stirred at room temperature for 1 h, loaded onto Varian™ SCX column, and washed with CH3OH (5 mL×2). Product was eluted off using 2 N NH3 in CH3OH (5 mL) and concentrated. The residue was dissolved in methanol (1 mL) and 4 N HCl in dioxane (0.50 mL) was added. The solution was stirred at room temperature overnight and concentrated. The residue was dissolved in methanol, loaded onto Varian™ SCX column, washed with CH3OH (5 mL×2), and eluted off using 2 N NH3 in CH3OH (5 mL). Concentration and preparative TLC (SiO2, ethyl acetate/MeOH=5/1) afforded 4-[{N-(2-amino-4,5-difluorobenzoyl)glycyl}aminomethyl]-1-(benzo[c]furazan-5-yl)piperidine (Compound No. 2130) (3.6 mg, 16%): The purity was determined by RPLC/MS (87%); ESI/MS m/e 459.3 (M++H, C22H24F2N6O3).

후처리

  1. temperatureThe mixture was cooled to room temperature
  2. washwashed with CH3OH (5 mL×2)
  3. washProduct was eluted off
  4. concentrationconcentrated
  5. additionTo the resulting material were added chloroform (1.5 mL) and phenyl isocyanate (0.075 mL)
  6. stirringthe solution was stirred at room temperature for 1 h
  7. washwashed with CH3OH (5 mL×2)
  8. washProduct was eluted off
  9. concentrationconcentrated
  10. dissolutionThe residue was dissolved in methanol (1 mL)
  11. addition4 N HCl in dioxane (0.50 mL) was added
  12. stirringThe solution was stirred at room temperature overnight
  13. concentrationconcentrated
  14. dissolutionThe residue was dissolved in methanol
  15. washwashed with CH3OH (5 mL×2)
  16. washeluted off
  17. concentrationConcentration and preparative TLC (SiO2, ethyl acetate/MeOH=5/1)

출처 및 근거

ORD 기록
ord-472e39f9e7e44251bdb3e58ffb5c4e8b
출처 데이터셋
uspto-grants-2002_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06362177B1

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트